Skip to main content
Alembic Pharmaceuticals Limited (NSE:APLLTD)
India flag India · Delayed Price · Currency is INR
899.80
-1.95 (-0.22%)
At close: Dec 5, 2025

Alembic Pharmaceuticals Revenue

Alembic Pharmaceuticals had revenue of 19.10B INR in the quarter ending September 30, 2025, with 15.91% growth. This brings the company's revenue in the last twelve months to 70.83B, up 11.42% year-over-year. In the fiscal year ending March 31, 2025, Alembic Pharmaceuticals had annual revenue of 66.72B with 7.12% growth.

Revenue (ttm)
70.83B
Revenue Growth
+11.42%
P/S Ratio
2.50
Revenue / Employee
4.27M
Employees
16,571
Market Cap
176.87B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202566.72B4.43B7.12%
Mar 31, 202462.29B5.76B10.19%
Mar 31, 202356.53B3.47B6.54%
Mar 31, 202253.06B-873.40M-1.62%
Mar 31, 202153.93B7.87B17.10%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 549.64B
Divi's Laboratories 100.29B
Cipla 279.66B
Apollo Hospitals Enterprise 232.65B
Zydus Lifesciences 244.94B
Mankind Pharma 135.46B
Aurobindo Pharma 325.14B
Fortis Healthcare 84.37B
Revenue Rankings

Alembic Pharmaceuticals News

More News